HyperhomocysteinemiaE72.-

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

An elevated homocysteine level is found in about 5% of the normal population. It was found that this finding can be detected in 10% of thrombosis patients. It is suspected that hyperhomocysteinemia is a risk factor for thrombosis.

EtiopathogenesisThis section has been translated automatically.

Homocysteine is a metabolide in the breakdown of methionine, which is metabolized via vitamin B12 and methylenetetrahydrofolic acid-dependent methionine synthetase. A gene mutation of methylenetetrahydrofolic acid reductase by a mutation in GC 677 T leads to increased homocysteine formation. The normal level is 5.5 mg/l. Compared to other risk factors for thrombosis formation, a genetic mutation of methylenetetrahydrofolic acid is comparatively mild. Detection is by immunoassay or gas chromatography.

LiteratureThis section has been translated automatically.

HA Neumann (2014) The coagulation system. ABW-Wissenschaftsverlag GmbH Berlin S. 232f.

Authors

Last updated on: 29.10.2020